WANG Ting, BI Weihong. Effect of large dose shock therapy of calcitriol on the treatment of the patients with end-stage renal disease complicated with secondary hyperparathyroidism[J]. Journal of Clinical Medicine in Practice, 2014, (17): 29-32,43. DOI: 10.7619/jcmp.201417009
Citation: WANG Ting, BI Weihong. Effect of large dose shock therapy of calcitriol on the treatment of the patients with end-stage renal disease complicated with secondary hyperparathyroidism[J]. Journal of Clinical Medicine in Practice, 2014, (17): 29-32,43. DOI: 10.7619/jcmp.201417009

Effect of large dose shock therapy of calcitriol on the treatment of the patients with end-stage renal disease complicated with secondary hyperparathyroidism

More Information
  • Published Date: October 16, 2014
  • Obj ective To observe and analyze the curative effect of large dose shock therapy of calcitriol on the treatment of the patients with end-stage renal disease (ESRD)complicated with secondary hyperparathyroidism (SHPT).Methods 60 patients with ESRD complicated with mod-erate or severe SHPT were selected as the research obj ects and randomly divided into the observation group and the control group,30 cases in each group.The patients in the observation group were treated with large dose shock therapy of calcitriol,while the patients in the control group were treated with routine dose therapy of calcitriol.The serum levels of calcium,phosphorus,parathy-roid hormone (PTH),hemoglobin (Hb)and hematocrit (HCT)of the patients in the two groups before and after the treatment were detected.The improvements of the skin itching of the patients were evaluated.Results The serum PTH level and the serum phosphorus levels of the patients in the two groups after the treatment were significantly lower than those before the treatment (P <0 .05 ),and the serum PTH level and the serum phosphorus levels of the patients in the observation group after the treatment were significantly lower than those in the control group (P<0 .05 ).The serum calcium level of the patients in the two groups after the treatment were significantly higher than that before the treatment (P<0 .0 5 ),and the serum calcium level of the patients in the observation group after the treatment were significantly higher than that in the control group (P<0 .05 ).The clinical efficacy in improving skin itching of the patients in the two groups were 90%and 40%,the clinical efficiency of the observation group was significantly higher than that of the control group (P<0 .05 ).Meanwhile,the proportion of the patients with the curative ef-fect of“significant”in the observation group was significantly higher than that in control group (P<0 .05 ).Hb and HCT levels of the patients in the two groups after the treatment were signif-icantly higher than those before the treatment (P<0 .05 ),and Hb and HCT levels of the patients in the observation group after the treatment were significantly higher than those in the control group (P<0 .05 ).Conclusion Application of large doses shock therapy of calcitriol in the treat-ment of ESRD complicated with SHPT can rectify the imbalance calcium and phosphorus metabolism of the patients rapidly,reduced the serum PTH level of the patients significantly,and relieve significantly the symptoms of skin itching or anemia of the patients.
  • 张艳, 黄金. 终末期肾病维持性血液透析患者依从性研究现状 [J]. 齐鲁护理杂志, 2012, (12):43.doi: 10.3969/j.issn.1006-7256.2012.12.021.
    万力, 杨林. 终末期肾病患者矿物质和骨异常的诊治进展 [J]. 医学综述, 2014(4):691.
    温静. 高频超声在继发性甲状旁腺功能亢进中的应用价值 [J]. 武警后勤学院学报(医学版), 2013, (12):1089.
    袁静, 吴龙, 查艳. 贵阳市终末期肾病维持血液透析患者现况调查 [J]. 临床荟萃, 2013(2):144.doi: 10.3969/j.issn.1004-583X.2013.02.008.
    谭焕源. 慢性肾功能衰竭继发性甲状旁腺功能亢进的治疗进展 [J]. 中国老年保健医学, 2013(3):74.doi: 10.3969/j.issn.1672-4860.2013.03.035.
    赖桂兰, 郭宗琳, 欧文芳. 维持性血液透析患者继发性甲状旁腺功能亢进超声表现及相关因素分析 [J]. 西部医学, 2013, (11):1718.doi: 10.3969/j.issn.1672-3511.2013.11.044.
    肖庆璇, 秦耀荣, 胡洁萍. 维持性血液透析患者继发性甲状旁腺功能亢进相关因素分析及护理对策 [J]. 实用临床医药杂志, 2014(2):4.
    周春柳. 维持性血液透析患者继发性甲状旁腺功能亢进治疗进展 [J]. 大家健康(学术版), 2013, (15):193.
    李英. 继发性甲状旁腺功能亢进的治疗现状 [J]. 中华肾病研究电子杂志, 2013(2):70.doi: 10.3877/cma.j.issn.2095-3216.2013.02.004.
    卢建跃, 孙新增, 张霆. 慢性肾病合并甲状旁腺亢进的外科治疗 [J]. 中国中西医结合外科杂志, 2014(1):64.
    宋莹, 夏燕平. 血液透析联合血液灌流治疗慢性肾衰竭并发继发性甲状旁腺功能亢进临床观察 [J]. 现代医药卫生, 2013, (23):3533.doi: 10.3969/j.issn.1009-5519.2013.23.006.
    丁璐. 骨化三醇对不同人群骨密度改善情况的研究 [J]. 中国医药导刊, 2013(7):1231.
    张建荣. 骨化三醇注射液治疗继发性甲状旁腺功能亢进的研究进展 [J]. 中国血液净化, 2011(2):114.doi: 10.3969/j.issn.1671-4091.2011.02.016.
    刘春秋, 刘雷, 李良志. 骨化三醇对维持性血液透析患者微炎症及氧化性应激状态的影响研究 [J]. 中国全科医学, 2013(6):516.
    Zwiech R, Dryja P, Pacina D. The assessment of cy-nacalcet (Mimpara)accompanied by alfacalcidol treatment ef-ficacy in haemodialysis patients with different secondary hy-perparathyroidism severity recognized by iPTH [J]. Wiadomosci Lekarskie, 2011(4):267.
    Sprague S M, Coyne D. Control of secondary hyper-parathyroidism by vitamin D receptor agonists in chronic kid-ney disease [J]. Clin J Am Soc Nephrol, 2010(3):512.
    冯跃华. 血液透析滤过联合骨化三醇治疗透析继发甲旁亢的临床研究 [J]. 浙江实用医学, 2013(3):187.

Catalog

    Article views (306) PDF downloads (0) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return